Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients

Abstract Disease-modifying therapies (DMT) administered to patients with multiple sclerosis (MS) can influence immune responses to SARS-CoV-2 and vaccine efficacy. However, data on the detailed phenotypic, functional and metabolic characteristics of antigen (Ag)-specific cells following the third do...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, Moritz Rau, Nikolaos Paschalidis, Rebecca Borella, Elena Santacroce, Annamaria Paolini, Lara Gibellini, Alin Liviu Ciobanu, Michela Cuccorese, Tommaso Trenti, Ignacio Rubio, Francesca Vitetta, Martina Cardi, Rafael José Argüello, Diana Ferraro, Andrea Cossarizza
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Portfolio 2024-03-01
Series:	Nature Communications
Acceso en liña:	https://doi.org/10.1038/s41467-024-47013-0
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!